The 5-HT7 receptor and disorders of the nervous system: an overview
Open accessAbstract
Rationale The 5-HT(7) receptor is a more recently discovered G-protein-coupled receptor for serotonin. The functions and possible clinical relevance of this receptor are not yet fully understood.Objective The present paper reviews to what extent the use of animal models of human psychiatric and neurological disorders have implicated the 5-HT(7) receptor in such disorders. The studies have used a combination of pharmacological and genetic tools targeting the receptor to evaluate effects on behavior.Results Models of anxiety and schizophrenia have yielded mixed results with no clear role for the 5-HT(7) receptor described in these disorders. Some data are available for epilepsy, migraine, and pain but it is still very early to draw any definitive conclusions. There is a considerable amount of evidence supporting a role for the 5-HT(7) receptor in depression. Both blockade and inactivation of the receptor have resulted in an antidepressant-like profile in models of depression. Supporting evidence has also been obtained in sleep studies. Especially interesting are the augmented effects achieved by combining antidepressants and 5-HT(7) receptor antagonists. The antidepressant effect of amisulpride has been shown to most likely be mediated by the 5-HT(7) receptor.Conclusions The use of pharmacological and genetic tools in preclinical animal models strongly supports a role for the 5-HT(7) receptor in depression. Indirect evidence exists showing that 5-HT(7) receptor antagonism is clinically useful in the treatment of depression. Available data also indicate a possible involvement of the 5-HT(7) receptor in anxiety, epilepsy, pain, and schizophrenia.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In rats, antagonizing the 5-HT7 receptor with amisulpride ameliorates the negative effects of chronic restraint stress on set-shifting.
“the negative effects of chronic restraint stress on set-shifting were ameliorated by antagonizing the 5-HT7 receptor, which is implicated in the cognitive and behavioral manifestation of depression, with amisulpride (Hedlund 2009, Hedlund et al 2005, Leopoldo et al 2011, Nikiforuk & Popik 2013).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Hedlund 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166 · see citing works
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1× · see citing works
“The forced swim test and the tail suspension test are two of the most common behavioral models for evaluating the antidepressant potential of a drug or to evaluate the phenotype of transgenic animals with respect to depression (Cryan et al. 2002; Cryan and Holmes 2005).”
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484 · see citing works
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198 · see citing works
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 1× · see citing works
“Chronic unpredictable mild stress is a model that attempts to induce a depression-like state in laboratory animals (Willner et al. 1992).”
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S. M., Arrington, E. G., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 971 · see citing works
Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., Foye, P. E., Racke, M. M., Slone, A. L., Siegel, B. W., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90149-l · Cited by 691 · see citing works
Ruat, M., Traiffort, É., Leurs, R., Tardivel‐Lacombe, J., Díaz, J., Arrang, J., & Schwartz, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 617 · see citing works
Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W., & Sibley, D. R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13616-x · Cited by 598 · see citing works
Choudhary, M. S., Craigo, S. C., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592 · see citing works
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Bard, J., Zgombick, J. M., Adham, N., VAYSSE, P. J. ‐., Branchek, T. A., & Weinshank, R. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49479-9 · Cited by 533 · see citing works
Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., Wikstr�m, H., Arvidsson, L. E., Hacksell, U., & Nilsson, J. (1982) · Journal of Neural Transmission · doi:10.1007/bf01276574 · Cited by 515 · see citing works
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Shen, Y., Monsma, F. J., Metcalf, M. A., José, P. A., Hamblin, M. W., & Sibley, D. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46830-x · Cited by 508 · see citing works
Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics
Cohrs, S. (2008) · CNS Drugs · doi:10.2165/00023210-200822110-00004 · Cited by 433 · see citing works
Lawler, C. P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 409 · see citing works
Functional, molecular and pharmacological advances in 5-HT receptor research
Hedlund, P. B., & Sutcliffe, J. G. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.002 · Cited by 350 · see citing works
Self-citationCharacterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist
Hagan, J. J., Price, G. W., Jeffrey, P., Deeks, N. J., Stean, T. O., Piper, D. C., Smith, M. I., Upton, N., Medhurst, A. D., Middlemiss, D. N., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703357 · Cited by 288 · see citing works
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
Abbas, A. I., Hedlund, P. B., Huang, X., Tran, T. B., Meltzer, H. Y., & Roth, B. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1521-8 · Cited by 286 · see citing works
Self-citation5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., & Sutcliffe, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.012 · Cited by 281 · see citing works
Self-citationBerman, R. M., Fava, M., Thase, M. E., Trivedi, M. H., Swanink, R., McQuade, R. D., Carson, W. H., Adson, D., Taylor, L., Hazel, J., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900020216 · Cited by 260 · see citing works
Lovell, P. J., Bromidge, S. M., Dabbs, S., Duckworth, D. M., Forbes, I. T., Jennings, A. J., King, F. D., Middlemiss, D. N., Rahman, S. K., Saunders, D. V., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm991151j · Cited by 252 · see citing works
Nicolas, L. B., Kolb, Y., & Prinssen, E. P. M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.015 · Cited by 234 · see citing works
Wesołowska, A., Nikiforuk, A., Stachowicz, K., & Tatarczynska, E. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.017 · Cited by 230 · see citing works
Guscott, M. R., Bristow, L. J., Hadingham, K. L., Rosahl, T. W., Beer, M. S., Stanton, J. A., Bromidge, F. A., Owens, A. P., Huscroft, I. T., Myers, J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.015 · Cited by 229 · see citing works
Dogrul, A. B., Ossipov, M. H., & Porreca, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.001 · Cited by 229 · see citing works
BindingDB (2011) · PubMed · doi:10.7270/q2154fjq · Cited by 224 · see citing works
Roth, B. L., Craigo, S. C., Choudhary, M. S., Uluer, A., Monsma, F. J., Shen, Y., Meltzer, H. Y., & Sibley, D. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38596-4 · Cited by 214 · see citing works
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents
Hedlund, P. B., Kelly, L., Mazur, C., Lovenberg, T. W., Sutcliffe, J. G., & Bonaventure, P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.031 · Cited by 192 · see citing works
Self-citationThomas, D. W., & Hagan, J. J. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482633 · Cited by 184 · see citing works
No hypothermic response to serotonin in 5-HT 7 receptor knockout mice
Hedlund, P. B., Danielson, P. E., Thomas, E. A., Slanina, K. A., Carson, M. J., & Sutcliffe, J. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337340100 · Cited by 182 · see citing works
Self-citationHeyman, I. (2006) · BMJ · doi:10.1136/bmj.333.7565.424 · Cited by 180 · see citing works
Glass, J. D., Grossman, G. H., Farnbauch, L. A., & DiNardo, L. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07451.2003 · Cited by 176 · see citing works
Elucidation of the neurobiology of depression: insights from a novel genetic animal model
Yadid, G., Nakash, R., Roth‐Deri, I., Tamar, G., Kinor, N., Gispan, I. H., & Zangen, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00018-6 · Cited by 171 · see citing works
Bonaventure, P., Kelly, L., Aluisio, L. E., Shelton, J. E., Lord, B., Galici, R., Miller, K. L., Atack, J. R., Lovenberg, T. W., & Dugovic, C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119404 · Cited by 170 · see citing works
Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus
Mullins, U. L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00041-x · Cited by 166 · see citing works
Mice lacking 5‐HT7 receptors show specific impairments in contextual learning
Roberts, A. J., Krucker, T., Levy, C. L., Slanina, K. A., Sutcliffe, J. G., & Hedlund, P. B. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03288.x · Cited by 149 · see citing works
Self-citationStudies on the neuroendocrine role of serotonin.
Jørgensen, H. S. (2007) · PubMed · Cited by 144 · see citing works
Brenchat, A., Romero, L. I., Garcı́a, M., Pujol, M., Burgueño, J., Torrens, A., Hamon, M., Baeyens, J. M., Buschmann, H., Zamanillo, D., et al. (2009) · Pain · doi:10.1016/j.pain.2008.11.009 · Cited by 142 · see citing works
Ehlen, J. C., Grossman, G. H., & Glass, J. D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05351.2001 · Cited by 139 · see citing works
Sprouse, J. S., Reynolds, L. S., Li, X., Braselton, J. P., & Schmidt, A. W. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.007 · Cited by 137 · see citing works
5-HT1-like receptor agonists and the pathophysiology of migraine
Saxena, P. R., & Ferrari, M. D. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90238-1 · Cited by 134 · see citing works
Li, Y., Wang, F., Pan, Y., Qiang, L.-Q., Cheng, G. S., Zhang, W., & Kong, L. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.01.006 · Cited by 134 · see citing works
5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons
Ying, S.-W., & Rusak, B. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00102-9 · Cited by 131 · see citing works
Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G., & Perrone‐Capano, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300962 · Cited by 130 · see citing works
Doly, S., Fischer, J., Brisorgueil, M., Vergé, D., & Conrath, M. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20667 · Cited by 129 · see citing works
SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats
Thomas, D. R., Melotto, S., Massagrande, M., Gribble, A. D., Jeffrey, P. D., Stevens, A. J., Deeks, N. J., Eddershaw, P. J., Fenwick, S. H., Riley, G. J., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705290 · Cited by 127 · see citing works
The 5-HT7 receptor is involved in allocentric spatial memory information processing
Sarkisyan, G., & Hedlund, P. B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.011 · Cited by 126 · see citing works
Self-citationSerotonin pharmacology in the gastrointestinal tract: a review
Beattie, D. T., & Smith, J. A. M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0276-9 · Cited by 121 · see citing works
Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia
Pouzet, B., Didriksen, M., & Arnt, J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00744-4 · Cited by 120 · see citing works
Amisulpride versus imipramine and placebo in dysthymia and major depression
Lecrubier, Y., Boyer, P., Turjanski, S., & Rein, W. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)00103-6 · Cited by 118 · see citing works
Tetrahydrobenzindoles: Selective Antagonists of the 5-HT7Receptor
Kikuchi, C., Nagaso, H., Hiranuma, T., & Koyama, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980519u · Cited by 118 · see citing works
Wesołowska, A., Tatarczynska, E., Nikiforuk, A., & Chojnacka-Wójcik, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.001 · Cited by 115 · see citing works
Wesołowska, A., Nikiforuk, A., & Stachowicz, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.064 · Cited by 112 · see citing works
Smeraldi, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00139-0 · Cited by 104 · see citing works
Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test
Rocha-González, H. I., Meneses, A., Carlton, S. M., & Granados‐Soto, V. (2005) · Pain · doi:10.1016/j.pain.2005.06.011 · Cited by 99 · see citing works
Dogrul, A. B., & Seyrek, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706854 · Cited by 98 · see citing works
Terrón, J. A., & Falcón‐Neri, A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702580 · Cited by 90 · see citing works
Gráf, M., Jakus, R., Kántor, S., Lévay, G. I., & Bagdy, G. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.072 · Cited by 89 · see citing works
Effect of 5-HT7 antagonist SB-269970 in the modulation of working and reference memory in the rat
Gasbarri, A., Cifariello, A., Pompili, A., & Meneses, A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.020 · Cited by 87 · see citing works
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Hedlund, P. B., & Sutcliffe, J. G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.054 · Cited by 84 · see citing works
Self-citationResponse of the Mouse Circadian System to Serotonin 1A/2/7 Agonists in vivo: Surprisingly Little
Antle, M. C., Ogilvie, M. D., Pickard, G. E., & Mistlberger, R. E. (2003) · Journal of Biological Rhythms · doi:10.1177/0748730403251805 · Cited by 82 · see citing works
The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behavior
Ballaz, S., Akil, H., & Watson, S. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.043 · Cited by 80 · see citing works
Ballaz, S., Akil, H., & Watson, S. J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.024 · Cited by 68 · see citing works
Eriksson, T. M., Golkar, A., Ekstrom, J. C., Svenningsson, P., & Ögren, S. O. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.026 · Cited by 68 · see citing works
Villalón, C. M., Centurión, D., Estrada, M. L., Terrón, J. A., & Sánchez‐López, A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701020 · Cited by 68 · see citing works
New light on the serotonergic paradox in the rat circadian system
Cuesta, M., Clesse, D., Pévet, P., & Challet, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06128.x · Cited by 67 · see citing works
Leo, D., Adriani, W., Cavaliere, C., Cirillo, G., Marco, E. M., Romano, E., di Porzio, U., Papa, M., Perrone‐Capano, C., & Giovanni Laviola, A. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00486.x · Cited by 66 · see citing works
Ikeda, M., Iwata, N., Kitajima, T., Suzuki, T., Yamanouchi, Y., Kinoshita, Y., & Ozaki, N. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300901 · Cited by 65 · see citing works
Galici, R., Boggs, J. D., Miller, K. L., Bonaventure, P., & Atack, J. R. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f62d8c · Cited by 64 · see citing works
Bonaventure, P., Nepomuceno, D. H., Hein, L., Sutcliffe, J. G., Lovenberg, T. W., & Hedlund, P. B. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.014 · Cited by 64 · see citing works
Self-citationWesołowska, A., & Kowalska, M. (2008) · PubMed · Cited by 60 · see citing works
East, S. Z., Burnet, P. W. J., Kerwin, R. W., & Harrison, P. J. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00323-1 · Cited by 60 · see citing works
Read, K. E., Sanger, G. J., & Ramage, A. G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705399 · Cited by 58 · see citing works
Harte, S. E., Kender, R. G., & Borszcz, G. S. (2004) · Pain · doi:10.1016/j.pain.2004.11.023 · Cited by 55 · see citing works
Duncan, M. J., Grear, K. E., & Hoskins, M. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.025 · Cited by 54 · see citing works
Bourson, A., Kapps, V., Zwingelstein, C., Rudler, A., Boess, F., & Sleight, A. J. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005123 · Cited by 53 · see citing works
Semenova, S., Geyer, M. A., Sutcliffe, J. G., Markou, A., & Hedlund, P. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.011 · Cited by 53 · see citing works
Self-citationSprouse, J. S., Li, X., Stock, J. L., McNeish, J. D., & Reynolds, L. S. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730404273432 · Cited by 50 · see citing works
Witkin, J. M., Baez, M., Yu, J., Barton, M. E., & Shannon, H. E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.03.017 · Cited by 49 · see citing works
de Freitas, R. L., Ferreira, C. M. D. R., Urbina, M., Marino, A., Carvalho, A. D., Butera, G., de Oliveira, A. M., & Coimbra, N. C. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.003 · Cited by 40 · see citing works
Graveleau, C., Paust, H., Schmidt-Grimminger, D., & Mukhopadhyay, A. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6448 · Cited by 38 · see citing works
5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats
Terrón, J. A., & Martínez-García, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.019 · Cited by 36 · see citing works
5‐hydroxytryptamine induced relaxation in the pig urinary bladder neck
Recio, P., Barahona, M. V., Orensanz, L. M., Bustamante, S., Martı́nez, A. C., Benedito, S., García‐Sacristán, A., Prieto, D., & Hernández, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00144.x · Cited by 35 · see citing works
Serotonin 5-HT7receptors mediate relaxation of porcine pial veins
Ishine, T., Bouchelet, I., Hamel, É., & Lee, T. J.-F. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.3.h907 · Cited by 33 · see citing works
Bosker, F. J., Folgering, J. H. A., Gladkevich, A. V., Schmidt, A. W., van der Hart, M. G. C., Sprouse, J. S., den Boer, J. A., Westerink, B. H. C., & Cremers, T. I. F. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05850.x · Cited by 30 · see citing works
Shelton, J. E., Bonaventure, P., Li, X., Yun, S., Lovenberg, T. W., & Dugovic, C. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.014 · Cited by 30 · see citing works
Wei, Z., Wang, L., Xuan, J., Che, R., Du, J., Qin, S., Xing, Y., Gu, B., Yang, L., Li, H., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.02.008 · Cited by 26 · see citing works
Yu, G.-D., Liu, Y.-L., Jiang, X., Guo, S., Zhang, H.-Q., Yin, Q.-Z., & Hisamitsu, T. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00462-7 · Cited by 20 · see citing works
Kogan, H. A., Marsden, C. A., & Fone, K. C. F. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02003-4 · Cited by 19 · see citing works
Recent Advances on the 5-HT5A, 5-HT6 and 5-HT7 Receptors
Shireman, B. T., Bonaventure, P., & Carruthers, N. I. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00002-x · Cited by 12 · see citing works
Martínez‐García, E., García‐Iglesias, B. B., & Terrón, J. A. (2009) · Autonomic and Autacoid Pharmacology · doi:10.1111/j.1474-8673.2009.00430.x · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 92 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Sleep disturbance as transdiagnostic: Consideration of neurobiological mechanisms
Harvey, A. G., Murray, G., Chandler, R. A., & Soehner, A. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.003 · Cited by 609 · see citing works
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547 · see citing works
Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 354 · see citing works
Loebel, A. D., Cucchiaro, J. B., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. S. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070984 · Cited by 340 · see citing works
Suppes, T., Silva, R., Cucchiaro, J., Mao, Y., Targum, S., Streicher, C., Pikalov, A., & Loebel, A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060770 · Cited by 322 · see citing works
Serotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311 · see citing works
Barnes, N. M., Ahern, G. P., Bécamel, C., Bockaert, J., Camilleri, M., Chaumont‐Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C. F., Gershon, M. D., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 264 · see citing works
Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
Hatzigiakoumis, D. S., Martinotti, G., Giannantonio, M. D., & Janiri, L. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00010 · Cited by 238 · see citing works
Central 5-HT receptors and their function; present and future
Sharp, T., & Barnes, N. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108155 · Cited by 227 · see citing works
Canal, C. E., & Morgan, D. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1333 · Cited by 223 · see citing works
Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis
Daniel, S., & Rainnie, D. G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.178 · Cited by 213 · see citing works
Brain serotonergic circuitries
Charnay, Y., & Léger, L. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.4/ycharnay · Cited by 211 · see citing works
Leopoldo, M., Lacivita, E., Berardi, F., Perrone, R., & Hedlund, P. B. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.013 · Cited by 198 · see citing works
Self-citationRenner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A. E., Dityatev, A. E., Gorinski, N., Guseva, D., Galil, D. A., Fröhlich, M., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101337 · Cited by 198 · see citing works
Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy
Adelöw, C., Andersson, T., Ahlbom, A., & Tomson, T. (2012) · Neurology · doi:10.1212/wnl.0b013e318245f461 · Cited by 196 · see citing works
HTR7 Mediates Serotonergic Acute and Chronic Itch
Morita, T., McClain, S. P., Batia, L. M., Pellegrino, M., Wilson, S. R., Kienzler, M. A., Lyman, K. A., Olsen, A. S. B., Wong, J. F., Stucky, C. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.044 · Cited by 186 · see citing works
Prefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176 · see citing works
Pehrson, A. L., & Sanchez, C. (2014) · CNS Spectrums · doi:10.1017/s1092852913000540 · Cited by 161 · see citing works
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
Mnie‐Filali, O., Faure, C., Lambás‐Señas, L., Mansari, M. E., Belblidia, H., Gondard, E., Etiévant, A., Scarna, H., Didier, A., Bérod, A., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.13 · Cited by 158 · see citing works
5-HT receptors and reward-related behaviour: A review
Hayes, D. J., & Greenshaw, A. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.005 · Cited by 146 · see citing works
Kim, J., Bridle, B. W., Ghia, J., Wang, H., Syed, S. N., Manocha, M. M., Palanivel, R., Shajib, M. S., Wan, Y., Hedlund, P. B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201887 · Cited by 139 · see citing works
Self-citationThe serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
Köhler, S., Cierpinsky, K., Kronenberg, G., & Adli, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609072 · Cited by 137 · see citing works
DelBello, M. P., Goldman, R., Phillips, D., Deng, L., Cucchiaro, J., & Loebel, A. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.10.006 · Cited by 135 · see citing works
Costa, L., Spatuzza, M., D’Antoni, S., Bonaccorso, C. M., Trovato, C., Musumeci, S. A., Leopoldo, M., Lacivita, E., Catania, M. V., & Ciranna, L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.008 · Cited by 129 · see citing works
Horiguchi, M., Huang, M., & Meltzer, H. Y. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180638 · Cited by 123 · see citing works
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
Meltzer, H. Y., Horiguchi, M., & Massey, B. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2137-8 · Cited by 120 · see citing works
Santello, M., & Nevian, T. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.003 · Cited by 118 · see citing works
Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix
Bijata, M., Labus, J., Guseva, D., Stawarski, M., Butzlaff, M., Dzwonek, J., Schneeberg, J., Böhm, K., Michaluk, P., Rusakov, D. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.023 · Cited by 119 · see citing works
Effects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 142 · see citing works
Tamada, K., Tomonaga, S., Hatanaka, F., Nakai, N., Takao, K., Miyakawa, T., Nakatani, J., & Takumi, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015126 · Cited by 115 · see citing works
The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior
Sarkisyan, G., Roberts, A. J., & Hedlund, P. B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.022 · Cited by 114 · see citing works
Self-citationMeltzer, H. Y., Rajagopal, L., Huang, M., Oyamada, Y., Kwon, S., & Horiguchi, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000928 · Cited by 114 · see citing works
Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112 · see citing works
5-HT Receptors and the Development of New Antidepressants
Ślifirski, G., Król, M., & Turło, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169015 · Cited by 111 · see citing works
The 5‐HT7 receptor in learning and memory
Roberts, A. J., & Hedlund, P. B. (2011) · Hippocampus · doi:10.1002/hipo.20938 · Cited by 108 · see citing works
Self-citationCiranna, L., & Catania, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00250 · Cited by 102 · see citing works
Novel Benzo[b]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of Action
Berrade, L., Aisa, B., Ramírez, M. J., Galiano, S., Guccione, S., Moltzau, L. R., Levy, F. O., Nicoletti, F., Battaglia, G., Molinaro, G., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000773 · Cited by 109 · see citing works
The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions
Groß, G., & Drescher, K. U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_7 · Cited by 109 · see citing works
Cellular mechanisms of the 5-HT7receptor-mediated signaling
Guseva, D., Wirth, A., & Ponimaskin, E. G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00306 · Cited by 99 · see citing works
Nikiforuk, A., Kos, T., Fijał, K., Hołuj, M., Rafa, D., & Popik, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066695 · Cited by 99 · see citing works
Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
Meltzer, H. Y. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_4 · Cited by 96 · see citing works
Developments in the field of antidepressants, where do we go now?
Artigas, F. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.04.013 · Cited by 95 · see citing works
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
Han, C., Wang, S., Kato, M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811901 · Cited by 92 · see citing works
Horiguchi, M., & Meltzer, H. Y. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2561-4 · Cited by 89 · see citing works
Genetic and biochemical changes of the serotonergic system in migraine pathobiology
Gasparini, C., Smith, R. A., & Griffiths, L. R. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0711-0 · Cited by 87 · see citing works
Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype
Cates, L. N., Roberts, A. J., Huitrón‐Reséndiz, S., & Hedlund, P. B. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.023 · Cited by 83 · see citing works
Self-citationLP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor
Hedlund, P. B., Leopoldo, M., Caccia, S., Sarkisyan, G., Fracasso, C., Martelli, G., Lacivita, E., Berardi, F., & Perrone, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.036 · Cited by 83 · see citing works
Self-citationFilippis, B. D., Nativio, P., Fabbri, A., Ricceri, L., Adriani, W., Lacivita, E., Leopoldo, M., Passarelli, F., Fuso, A., & Giovanni Laviola, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.105 · Cited by 81 · see citing works
The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
Speranza, L., Chambery, A., Domenico, M. D., Crispino, M., Severino, V., Volpicelli, F., Leopoldo, M., Bellenchi, G. C., di Porzio, U., & Perrone‐Capano, C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.026 · Cited by 79 · see citing works
Zajdel, P., Marciniec, K., Maślankiewicz, A., Satała, G., Duszyńska, B., Bojarski, A. J., Partyka, A., Jastrzębska‐Więsek, M., Wróbel‐Biedrawa, D., Wesołowska, A., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.039 · Cited by 68 · see citing works
Filippis, B. D., Chiodi, V., Adriani, W., Lacivita, E., Mallozzi, C., Leopoldo, M., Domenici, M. R., Fuso, A., & Giovanni Laviola, A. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00086 · Cited by 66 · see citing works
Exon‐disrupting deletions of NRXN1 in idiopathic generalized epilepsy
Møller, R. S., Weber, Y. G., Klitten, L. L., Trucks, H., Muhle, H., Kunz, W. S., Mefford, H. C., Franke, A., Kautza, M., Wolf, P., et al. (2013) · Epilepsia · doi:10.1111/epi.12078 · Cited by 66 · see citing works
The serotonin receptor 7 and the structural plasticity of brain circuits
Volpicelli, F., Speranza, L., di Porzio, U., Crispino, M., & Perrone‐Capano, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00318 · Cited by 65 · see citing works
Adriani, W., Travaglini, D., Lacivita, E., Saso, L., Leopoldo, M., & Giovanni Laviola, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.012 · Cited by 65 · see citing works
Hashemi-Firouzi, N., Komaki, A., Asl, S. S., & Shahidi, . (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.10.004 · Cited by 58 · see citing works
Waters, K. A., Stean, T. O., Hammond, B., Virley, D. J., Upton, N., Kew, J. N. C., & Hussain, I. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.009 · Cited by 58 · see citing works
The 5-HT7 receptor as a potential target for treating drug and alcohol abuse
Hauser, S. R., Hedlund, P. B., Roberts, A. J., Sari, Y., Bell, R. L., & Engleman, E. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00448 · Cited by 56 · see citing works
Self-citationMorein-Zamir, S., Craig, K. J., Ersche, K. D., Abbott, S., Muller, U., Fineberg, N. A., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1963-z · Cited by 54 · see citing works
Palmitoylation as a Functional Regulator of Neurotransmitter Receptors
Naumenko, V. S., & Ponimaskin, E. G. (2018) · Neural Plasticity · doi:10.1155/2018/5701348 · Cited by 55 · see citing works
Pytka, K., Partyka, A., Jastrzębska‐Więsek, M., Siwek, A., Głuch‐Lutwin, M., Mordyl, B., Kazek, G., Rapacz, A., Olczyk, A., Gałuszka, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142499 · Cited by 53 · see citing works
Shahidi, ., Asl, S. S., Komaki, A., & Hashemi-Firouzi, N. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4862-3 · Cited by 53 · see citing works
Farook, M. F., DeCuypere, M. G., Hyland, Κ., Takumi, T., LeDoux, M. S., & Reiter, L. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043030 · Cited by 49 · see citing works
Bonaventure, P., Aluisio, L. E., Shoblock, J. R., Boggs, J. D., Fraser, I. C., Lord, B., Lovenberg, T. W., & Galici, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020210 · Cited by 51 · see citing works
Use of antipsychotics in the treatment of depressive disorders.
Wang, P., & Si, T. (2013) · PubMed Central · doi:10.3969/j.issn.1002-0829.2013.03.002 · Cited by 50 · see citing works
Kato, T., Ishigooka, J., Miyajima, M., Watabe, K., Fujimori, T., Masuda, T., Higuchi, T., & Vieta, E. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13137 · Cited by 49 · see citing works
“This activity has been implicated in antidepressant like effect in animal models.(18) Consistent with this, lurasidone has demonstrated efficacy in animal models of depression.”
Result5-HT7 receptor signaling: improved therapeutic strategy in gut disorders
Kim, J., & Khan, W. I. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00396 · Cited by 49 · see citing works
Deardorff, W. J., & Grossberg, G. T. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.960842 · Cited by 49 · see citing works
Renoir, T., Pang, T. Y., Mo, C., Chan, G., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239798 · Cited by 48 · see citing works
The Role of Serotonin in Axon and Dendrite Growth
Trakhtenberg, E. F., & Goldberg, J. L. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-407178-0.00005-3 · Cited by 48 · see citing works
Çadırcı, E., Halıcı, Z., Bayır, Y., Albayrak, A., Karakuş, E., Polat, B., Ünal, D., Atamanalp, S. S., Aksak, S., & Gündoğdu, C. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.012 · Cited by 47 · see citing works
García‐Iglesias, B. B., Mendoza‐Garrido, M. E., Gutiérrez‐Ospina, G., Rangel‐Barajas, C., Noyola-Díaz, M., & Terrón, J. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.013 · Cited by 47 · see citing works
Tajiri, M., Hayata‐Takano, A., Seiriki, K., Ogata, K., Hazama, K., Shintani, N., Baba, A., & Hashimoto, H. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9861-y · Cited by 46 · see citing works
Wu, M., Liu, S., Hu, L., Qu, H., Pan, C., Lei, P., Shen, Y., & Yang, M. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.09.027 · Cited by 46 · see citing works
5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux
Huang, M., Horiguchi, M., Felix, A. R., & Meltzer, H. Y. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328352de40 · Cited by 45 · see citing works
Zajdel, P., Kurczab, R., Grychowska, K., Satała, G., Pawłowski, M., & Bojarski, A. J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.043 · Cited by 45 · see citing works
5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area.
Tokarski, K., Kusek, M., & Hess, G. (2011) · PubMed · Cited by 45 · see citing works
Nikiforuk, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.006 · Cited by 44 · see citing works
Serotonin receptor 5-HT7 regulates morphology and migratory properties of dendritic cells
Holst, K., Guseva, D., Schindler, S., Sixt, M., Braun, A. C., Chopra, H., Pabst, O., & Ponimaskin, E. G. (2015) · Journal of Cell Science · doi:10.1242/jcs.167999 · Cited by 44 · see citing works
Amisulpride promotes cognitive flexibility in rats: The role of 5-HT7 receptors
Nikiforuk, A., & Popik, P. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.008 · Cited by 43 · see citing works
Albayrak, A., Halıcı, Z., Çadırcı, E., Polat, B., Karakuş, E., Bayır, Y., Ünal, D., Atasoy, M., & Dogrul, A. B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.010 · Cited by 43 · see citing works
S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior
Stroth, N., & Svenningsson, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.003 · Cited by 43 · see citing works
Hazra, R., Guo, J. D., Dabrowska, J., & Rainnie, D. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.014 · Cited by 42 · see citing works
Efficacy of vortioxetine on the physical symptoms of major depressive disorder
Christensen, M. C., Florea, I., Lindstén, A., & Baldwin, D. S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118788826 · Cited by 42 · see citing works
5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice
Ulugöl, A., Oltulu, Ç., Gündüz, Ö., Citak, C., Carrara, R., Shaqaqi, M. R., Sanchez, A. M., & Dogrul, A. B. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.006 · Cited by 40 · see citing works
Westrich, L., Haddjeri, N., Dkhissi‐Benyahya, O., & Sánchez, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.015 · Cited by 40 · see citing works
Effects of 5-HT-7 receptor ligands on memory and cognition
Zareifopoulos, N., & Papatheodoropoulos, C. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.10.011 · Cited by 40 · see citing works
Drinkenburg, W. H. I. M., Ahnaou, A., & Ruigt, G. S. F. (2015) · Neuropsychobiology · doi:10.1159/000443175 · Cited by 37 · see citing works
The critical role of spinal 5-HT7 receptors in opioid and non-opioid type stress-induced analgesia
Yeşilyurt, Ö., Seyrek, M., Taşdemir, S., Kahraman, S., Deveci, M. S., Karakuş, E., Halıcı, Z., & Dogrul, A. B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.020 · Cited by 38 · see citing works
Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands
Zajdel, P., Marciniec, K., Maślankiewicz, A., Paluchowska, M. H., Satała, G., Partyka, A., Jastrzębska‐Więsek, M., Wróbel‐Biedrawa, D., Wesołowska, A., Duszyńska, B., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.044 · Cited by 37 · see citing works
Canese, R., Zoratto, F., Altabella, L., Porcari, P., Mercurio, L., de Pasquale, F., Butti, E., Martino, G., Lacivita, E., Leopoldo, M., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3639-6 · Cited by 36 · see citing works
Lemoine, L., Andriès, J., Bars, D. L., Billard, T., & Zimmer, L. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089185 · Cited by 36 · see citing works
Hogendorf, A. S., Hogendorf, A., Popiołek-Barczyk, K., Ciechanowska, A., Mika, J., Satała, G., Walczak, M., Latacz, G., Handzlik, J., Kieć‐Kononowicz, K., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.017 · Cited by 36 · see citing works
The Serotonin-7 Receptor as a Novel Therapeutic Target
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10bs06601gry · Cited by 35 · see citing works
Kusek, M., Sowa, J., Kamińska, K., Gołembiowska, K., Tokarski, K., & Hess, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00324 · Cited by 33 · see citing works
Vigli, D., Rusconi, L., Valenti, D., Montanara, P. L., Cosentino, L., Lacivita, E., Leopoldo, M., Amendola, E., Gross, C. T., Landsberger, N., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.018 · Cited by 33 · see citing works
Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapine
Reynolds, G. P. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311430112 · Cited by 33 · see citing works
Latacz, G., Hogendorf, A. S., Hogendorf, A., Lubelska, A., Wierońska, J. M., Woźniak, M., Cieślik, P., Kieć‐Kononowicz, K., Handzlik, J., & Bojarski, A. J. (2018) · MedChemComm · doi:10.1039/c8md00313k · Cited by 32 · see citing works
Agrawal, L., Korkutata, M., Vimal, S. K., Yadav, M. K., Bhattacharyya, S., & Shiga, T. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107969 · Cited by 31 · see citing works
Sanchez, M. G. D. B., Estrada-Camarena, E. M., Bélanger, N., Morissette, M., & Paolo, T. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.024 · Cited by 31 · see citing works
Guedes, R. C. A., de Araújo, M. D. G. R., Verçosa, T. C., Bion, F. M., de Sá, A. L., Pereira, A., & Abadie‐Guedes, R. (2017) · Brain Research · doi:10.1016/j.brainres.2017.07.011 · Cited by 30 · see citing works
- Authors
- Hedlund, P. B.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Hedlund, Peter B.
- Venue
- Psychopharmacology
- Published
- 2009-08-01
- Volume
- 206
- Issue
- 3
- Pages
- 345-354
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC2841472
- OpenAlex
- W1966819687
- Cited by
- 239
- References
- 92
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 11 · 2023: 4 · 2022: 13 · 2021: 2 · 2020: 11 · 2019: 7 · 2018: 13 · 2017: 19 · 2016: 11 · 2015: 25 · 2014: 19 · 2013: 23 · 2012: 31
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH73923, R01MH073923)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- 5-HT7 receptor, serotonin, G protein-coupled receptors, depression, antidepressant-like effects, 5-HT7 receptor antagonists, amisulpride, anxiety, schizophrenia, epilepsy, migraine, pain, sleep, animal models of psychiatric disorders
- MeSH terms
- Animals, Antidepressive Agents, Disease Models, Animal, Humans, Nervous System Diseases, Receptors, Serotonin, Serotonin Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review